Edited by: Jens Lykkesfeldt and Ulf Simonsen
Basic & Clinical Pharmacology & Toxicology publishes original scientific research and reviews and opinion pieces in all fields of toxicology and basic and clinical pharmacology, including experimental animal pharmacology and toxicology and molecular (genetic), biochemical and cellular pharmacology and toxicology. Basic & Clinical Pharmacology & Toxicology is the official journal of the Nordic societies for Pharmacology and Toxicology and its revenue supports the scientific communities within the field. Basic & Clinical Pharmacology & Toxicology strives to improve the scientific quality of publications in the field through our manuscript policy that details good scientific practices within experimental and clinical pharmacology and toxicology.
Journal Metrics
- 5.9CiteScore
- 3.3Journal Impact Factor
- 20%Acceptance rate
- 10 days Submission to first decision
Information about BCPT Prizes and BCPT-sponsored Activities.
Announcements
See our current Special Collections.
Brief Annual Report 2024 of financial activities of Nordic Association for the Publication of BCPT
A key objective of the Nordic Association for the Publication of BCPT is to be engaged in promoting research and education within basic and clinical pharmacology and toxicology, by supporting scientific meetings in the Nordic countries as well as engage in presenting prizes and awards to distinguished scientists.
Here is an overview of such activities in 2024.
Articles
Assessment of Rivaroxaban Plasma Concentration Using Chromogenic Anti‐Xa Assays and UHPLC–MS/MS in Chinese Patients With Atrial Fibrillation
- 30 July 2025
Xiao‐Jie‐An Capsule Alleviates Uterine Fibroids by Modulating Oestrogen–Progesterone Balance and Reducing Inflammatory Response
- 28 July 2025
Graphical Abstract
Triterpenoid From Persimmon Leaves (Diospyros kaki L.f.) Exerted Anti–Type 2 Diabetic Effects and No Toxicity in Experimental Animals
- 23 July 2025
Graphical Abstract
LW‐AFC Protects Against Neurological and Neuropsychiatric Effects of SARS‐CoV‐2 Spike Protein in Mice
- 23 July 2025
Graphical Abstract
The study shows SARS-CoV-2 spike protein causes neural damage in mice, and LW-AFC improves it by reducing neuroinflammation and enhancing mitochondrial metabolism.
Huoxin Pill Ameliorates Atrial Fibrillation by Modulating Autonomic Nervous Balance and Electrical Conduction Heterogeneity: Insights From Systems Pharmacology and Experimental Validation
- 22 July 2025
Graphical Abstract
This study demonstrates that Huoxin Pill (HXP) ameliorates atrial fibrillation (AF) by modulating autonomic balance and atrial electrical conduction heterogeneity in an ACh-CaCl2-induced AF rat model. HXP significantly reduced AF susceptibility and duration, restored sympathovagal balance, and improved atrial electrical homogeneity. Its multitarget mechanisms involve inhibition of structural remodeling, regulation of electrical remodeling, and autonomic modulation, providing novel insights for AF prevention and treatment.
Recent issues
Volume 137, Issue 3September 2025
Volume 137, Issue 2August 2025
Volume 137, Issue 1July 2025